Publications

  1. Dronca RS, Allred JB, Perez DG, Nevala WK, Lieser EA, Thompson M, Maples WJ, Creagan ET, Pockaj BA, Kaur JS, Moore TD, Marchello BT, Markovic SN. Phase II Study of Temozolomide (TMZ) and Everolimus (RAD001) Therapy for Metastatic Melanoma: A North Central Cancer Treatment Group Study, N0675. Am J Clin Oncol. 2014 Aug; 37(4):369-76.
    View PubMed
  2. Singh SD, Ryerson AB, Wu M, Kaur JS. Ovarian and uterine cancer incidence and mortality in American Indian and Alaska Native women, United States, 1999-2009. Am J Public Health. 2014 Jun; 104 Suppl 3:S423-31. Epub 2014 Apr 22.
    View PubMed
  3. White A, Richardson LC, Li C, Ekwueme DU, Kaur JS. Breast cancer mortality among American Indian and Alaska Native women, 1990-2009. Am J Public Health. 2014 Jun; 104 Suppl 3:S432-8. Epub 2014 Apr 22.
    View PubMed
  4. White MC, Espey DK, Swan J, Wiggins CL, Eheman C, Kaur JS. Disparities in cancer mortality and incidence among American Indians and Alaska Natives in the United States. Am J Public Health. 2014 Jun; 104 Suppl 3:S377-87. Epub 2014 Apr 22.
    View PubMed
  5. Kaur JS, Vierkant RA, Hobday T, Visscher D. Regional differences in breast cancer biomarkers in american Indian and Alaska native women. Cancer Epidemiol Biomarkers Prev. 2014 Mar; 23(3):409-15.
    View PubMed
  6. Swigris JJ, Streiner DL, Brown KK, Belkin A, Green KE, Wamboldt FS, Schwarz M, Zisman DA, Hunninghake G, Chapman J, Olman M, Lubell S, Morrison LD, Steele MP, Haram T, Roman J, Perez R, Perez T, Ryu JH, Utz JP, Limper AH, Daniels CE, Meiras K, Walsh S, Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis. Respir Med. 2014; 108(1):181-8.
  7. Creswell PD, Strickland R, Stephenson L, Pierce-Hudson K, Matloub J, Waukau J, Adams A, Kaur J, Remington PL. Look local: the value of cancer surveillance and reporting by American Indian clinics. Preventing Chronic Disease. 2013 Nov; 10:UNSP 130153.
  8. Kottschade LA, Grotz TE, Dronca RS, Salomao DR, Pulido JS, Wasif N, Jakub JW, Bagaria SP, Kumar R, Kaur JS, Morita SY, Moran SL, Nguyen JT, Nguyen EC, Hand JL, Erickson LA, Brewer JD, Baum CL, Miller RC, Swanson DL, Lowe V, Markovic SN. Rare Presentations of Primary Melanoma and Special Populations: A Systematic Review. Am J Clin Oncol. 2013 Apr 03. [Epub ahead of print]
    View PubMed
  9. Kottschade LA, Suman VJ, Perez DG, McWilliams RR, Kaur JS, Amatruda TT 3rd, Geoffroy FJ, Gross HM, Cohen PA, Jaslowski AJ, Kosel ML, Markovic SN. A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775. Cancer. 2013 Feb 1; 119(3):586-92. Epub 2012 Aug 22.
    View PubMed
  10. Pruthi S, Stange KJ, Malagrino GD Jr, Chawla KS, LaRusso NF, Kaur JS. Successful implementation of a telemedicine-based counseling program for high-risk patients with breast cancer. Mayo Clin Proc. 2013 Jan; 88(1):68-73.
    View PubMed
  11. Nowakowski KE, Tilburt JC, Kaur JS. Shared decision making in cancer screening and treatment decisions for American Indian and Alaska native communities: can we ethically calibrate interventions to patients' values? J Cancer Educ. 2012 Dec; 27(4):790-2.
    View PubMed
  12. Kaur JS, Coe K, Rowland J, Braun KL, Conde FA, Burhansstipanov L, Heiney S, Kagawa-Singer M, Lu Q, Witte C. Enhancing life after cancer in diverse communities. Cancer. 2012 Nov 1; 118(21):5366-73. Epub 2012 Mar 20.
    View PubMed
  13. Miles SL, Niles RM, Pittock S, Vile R, Davies J, Winters JL, Abu-Yaghi NE, Grothey A, Siddiqui M, Kaur J, Hartmann L, Kalli KR, Pease L, Kravitz D, Markovic S, Pulido JS. A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytes. Retina. 2012 Oct; 32(9):1959-66.
    View PubMed
  14. Warne D, Kaur J, Perdue D. American Indian/Alaska Native cancer policy: systemic approaches to reducing cancer disparities. J Cancer Educ. 2012 Apr; 27 Suppl 1:S18-23.
    View PubMed
  15. Burhansstipanov L, Dignan M, Jones KL, Krebs LU, Marchionda P, Kaur JS. Comparison of quality of life between Native and non-Native cancer survivors: Native and non-Native cancer survivors' QOL. J Cancer Educ. 2012 Apr; 27 Suppl 1:S106-13.
    View PubMed
  16. Kaur JS, Wiggins C, Burhansstipanov L. Introduction to SOE Special Issue. J Cancer Educ. 2012 Apr; 27 Suppl 1:S1-3.
    View PubMed
  17. Kaur JS, Petereit DG. Personalized medicine: challenge and promise. J Cancer Educ. 2012 Apr; 27(1 Suppl):S12-7.
    View PubMed
  18. Leontovich AA, Dronca RS, Suman VJ, Ashdown ML, Nevala WK, Thompson MA, Robinson A, Kottschade LA, Kaur JS, McWilliams RR, Ivanov LV, Croghan GA, Markovic SN. Fluctuation of systemic immunity in melanoma and implications for timing of therapy. Front Biosci (Elite Ed). 2012; 4:958-75. Epub 2012 Jan 01.
    View PubMed
  19. Dronca R, Allred JB, Perez DG, Nevala WK, Lieser EA, Thompson M, Maples WJ, Creagan ET, Pockaj BA, Kaur JS, Moore TD, Marchello BT, Markovic SN. Phase II Study of Temzolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma. Am J Clin Oncol. 2012.
    View PubMed
  20. Block MS, Suman VJ, Nevala WK, Kottschade LA, Creagan ET, Kaur JS, Quevedo JF, McWilliams RR, Markovic SN. Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine. Melanoma Res. 2011 Oct; 21(5):438-45.
    View PubMed
  21. Burhansstipanov L, O'Donnell J, Paisano R, Krebs LU, Kaur JS, Hill TA, Lovato MP. What a difference one person can make: a tribute to Mary P. Lovato. J Cancer Educ. 2011 Sep; 26(3):591-3.
    View PubMed
  22. Kamal AH, Swetz KM, Carey EC, Cheville AL, Liu H, Ruegg SR, Moynihan TJ, Sloan JA, Kaur JS. Palliative care consultations in patients with cancer: a Mayo Clinic 5-year review. J Oncol Pract. 2011 Jan; 7(1):48-53.
    View PubMed
  23. Larson BR, Looker S, Herrera DM, Creagan ET, Hayman SR, Kaur JS, Jatoi A. Cancer patients and their companion animals: results from a 309-patient survey on pet-related concerns and anxieties during chemotherapy. J Cancer Educ. 2010 Sep; 25(3):396-400. Epub 2010 Feb 24.
    View PubMed
  24. Burhansstipanov L, Krebs LU, Seals BF, Bradley AA, Kaur JS, Iron P, Dignan MB, Thiel C, Gamito E. Native American breast cancer survivors' physical conditions and quality of life. Cancer. 2010 Mar 15; 116(6):1560-71.
    View PubMed
  25. Gonzalez Bosquet J, Terstriep SA, Cliby WA, Brown-Jones M, Kaur JS, Podratz KC, Keeney GL. The impact of multi-modal therapy on survival for uterine carcinosarcomas. Gynecol Oncol. 2010 Mar; 116(3):419-23. Epub 2009 Nov 05.
    View PubMed
  26. Arenella C, Finke B, Domer T, Kaur JS, Merriman MP, Ousley A. Adaptation, dissemination, and evaluation of a cancer palliative care curriculum for the Indian health system. J Palliat Care. 2010 Spring; 26(1):15-21.
    View PubMed
  27. Galanis E, Hartmann LC, Cliby WA, Long HJ, Peethambaram PP, Barrette BA, Kaur JS, Haluska PJ Jr, Aderca I, Zollman PJ, Sloan JA, Keeney G, Atherton PJ, Podratz KC, Dowdy SC, Stanhope CR, Wilson TO, Federspiel MJ, Peng KW, Russell SJ. Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. Cancer Res. 2010 Feb 1; 70(3):875-82. Epub 2010 Jan 26.
    View PubMed
  28. Gonzalez Bosquet J, Terstriep SA, Cliby WA, Brown-Jones M, Kaur JS, Podratz KC, Keeney GL. The impact of multi-model therapy on survival for uterine carcinosarcomas Gynec Oncol (accepted for publication) 2010.
  29. Patten CA, Enoch C, Renner CC, Offord KP, Nevak C, Kelley SF, Thomas J, Decker PA, Hurt RD, Lanier A, Kaur JS. Focus groups of Alaska Native adolescent tobacco users: preferences for tobacco cessation interventions and barriers to participation. Health Educ Behav. 2009 Aug; 36(4):711-23. Epub 2007 Nov 29.
    View PubMed
  30. Matloub J, Creswell PD, Strickland R, Pierce K, Stephenson L, Waukau J, Kaur JS, Remington P. Lessons learned from a community-based participatory research project to improve American Indian cancer surveillance Progress in Community Health Partnerships. 2009; 3.1:47-52.
  31. Kaur J, NCI. A call to action Indian Country Today. 2008 Dec 16. [Epub ahead of print]
  32. Chu KC, Chen MS Jr, Dignan MB, Taylor E, Partridge E, Community Network Program Principal Investigators. Parallels between the development of therapeutic drugs and cancer health disparity programs: implications for Disparities Reduction. Cancer. 2008 Nov 15; 113(10):2790-6.
    View PubMed
  33. Wingo PA, King J, Swan J, Coughlin SS, Kaur JS, Erb-Alvarez JA, Jackson-Thompson J, Arambula Solomon TG. Breast cancer incidence among American Indian and Alaska Native women: US, 1999-2004. Cancer. 2008 Sep 1; 113(5 Suppl):1191-202.
    View PubMed
  34. Wiggins CL, Espey DK, Wingo PA, Kaur JS, Wilson RT, Swan J, Miller BA, Jim MA, Kelly JJ, Lanier AP. Cancer among American Indians and Alaska Natives in the United States, 1999-2004. Cancer. 2008 Sep 1; 113(5 Suppl):1142-52.
    View PubMed
  35. Wilson RT, Richardson LC, Kelly JJ, Kaur J, Jim MA, Lanier AP. Cancers of the urinary tract among American Indians and Alaska Natives in the United States, 1999-2004. Cancer. 2008 Sep 1; 113(5 Suppl):1213-24.
    View PubMed
  36. Kaur JS, Hampton JW. Cancer in American Indian and Alaska Native populations continues to threaten an aging population : the need for tribal, state, and federal action. Cancer. 2008 Sep 1; 113(5 Suppl):1117-9.
    View PubMed
  37. Patten CA, Renner CC, Decker PA, O'Campo E, Larsen K, Enoch C, Offord KP, Hurt RD, Lanier A, Kaur J. Tobacco use and cessation among pregnant Alaska Natives from Western Alaska enrolled in the WIC program, 2001-2002. Matern Child Health J. 2008 Jul; 12 Suppl 1:30-6. Epub 2008 Mar 14.
    View PubMed
  38. McKean H, Looker S, Hartmann LC, Hayman SR, Kaur JS, McWilliams RR, Peethambaram PP, Stahl JF, Jatoi A. Are cancer survivors/patients knowledgeable about osteoporosis? Results from a survey of 285 chemotherapy-treated cancer patients and their companions. J Nutr Educ Behav. 2008 May-Jun; 40(3):144-8.
    View PubMed
  39. Croghan G, Croghan I, Hurt R, Kaur J, Novotny P, Sloan J, DeKrey W, Steen P, Loprinzi C. A Comparison by Ethnicity of a 15 Mg/16 Hour Nicotine Patch Alone Versus Nicotine Nasal Spray Alone Verus Both. J Health Care for the Poor and Underserved. 2008.
    View PubMed
  40. Markovic S, Suman V, Nevala W, Geeraerts L, Pittelkow M, Ingle J, Creagan E, Kaur J, Erickson L, Rowland K, Morton R, Horvath W. Autologous Anti-Tumor Immunization: A Dose-Escalation Study of Aerosolized Sargramostim (Granulocyte Macrophage Colony Stimulating Factor) in the Treatment of Metastatic Melanoma to the Lung. Am J Clin Oncol. 2008; 31:573-9.
    View PubMed
  41. Domer T, Kaur JS. Palliative practice in Indian health. South Dakota Medicine Special Edition. 2008:36-40.
  42. Sideras K, Zahasky KM, Kaur JS. Response of cutaneous metastases from breast cancer to capecitabine. Clin Med Oncol. 2008; 2:415-8. Epub 2008 Apr 18.
    View PubMed
  43. Espey DK, Wu XC, Swan J, Wiggins C, Jim MA, Ward E, Wingo PA, Howe HL, Ries LA, Miller BA, Jemal A, Ahmed F, Cobb N, Kaur JS, Edwards BK. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer. 2007 Nov 15; 110(10):2119-52.
    View PubMed
  44. Bassil KL, Vakil C, Sanborn M, Cole DC, Kaur JS, Kerr KJ. Cancer health effects of pesticides - Systematic review. Can Fam Physician. 2007 Oct; 53:1705-11.
    View PubMed
  45. Markovic SN, Suman VJ, Rao RA, Ingle JN, Kaur JS, Erickson LA, Pitot HC, Croghan GA, McWilliams RR, Merchan J, Kottschade LA, Nevala WK, Uhl CB, Allred J, Creagan ET. A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma. Am J Clin Oncol. 2007 Jun; 30(3):303-9.
    View PubMed
  46. Kaur JS, Dignan M, Burhansstipanov L, Baukol P, Claus C. The "Spirit of Eagles" legacy. Cancer. 2006 Oct 15; 107(8 Suppl):1987-94.
    View PubMed
  47. Markovic SN, Suman VJ, Ingle JN, Kaur JS, Pitot HC, Loprinzi CL, Rao RD, Creagan ET, Pittelkow MR, Allred JB, Nevala WK, Celis E. Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization. Am J Clin Oncol. 2006 Aug; 29(4):352-60.
    View PubMed
  48. Delaunoit T, Burch PA, Reid JM, Camoriano JK, Kobayash T, Braich TA, Kaur JS, Rubin J, Erlichman C. A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors. Invest New Drugs. 2006 Jul; 24(4):327-33.
    View PubMed
  49. Baweja M, Suman VJ, Fitch TR, Mailliard JA, Bernath A, Rowland KM, Alberts SR, Kaur JS, Perez EA, Ncctg. Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients > or = 65 years of age: an NCCTG study. Ann Oncol. 2006 Apr; 17(4):623-9. Epub 2006 Mar 06.
    View PubMed
  50. Rao RD, Holtan SG, Ingle JN, Croghan GA, Kottschade LA, Creagan ET, Kaur JS, Pitot HC, Markovic SN. Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma. Cancer. 2006 Jan 15; 106(2):375-82.
    View PubMed
  51. Hayes N, Rollins R, Weinberg A, Brawley O, Baquet C, Kaur JS, Palafox NA. Cancer-related disparities: weathering the perfect storm through comprehensive cancer control approaches. Cancer Causes and Control. 2005 Oct; 16(Suppl 1):41-50.
    View PubMed
  52. Michalek AM, Mahoney MC, Gilbert A, Kaur J. Palliative care services: a survey of tribal health directors. The IHS Provider. 2005 May:118-9.
    View PubMed
  53. Choong NWW, Quevedo JF, Kaur JS. Small cell carcinoma of the urinary bladder - The Mayo Clinic experience. Cancer. 2005 Mar 15; 103(6):1172-8.
    View PubMed
  54. Kaur JS. The promise and the challenge of the spirit of EAGLES program. J Cancer Educ. 2005 Spr; 20(1 Suppl S):2-6.
    View PubMed
  55. Packer MM, Kaur JS, Hodge FS, Nan B, Trapp MA, Roubidoux MA. A survey of attendees at Native American health care conferences: Knowledge, attitudes, and practices about cigarette smoking. J Cancer Educ. 2005 Sum; 20(2):89-95.
    View PubMed
  56. Burhansstipanov L, Bemis L, Kaur JS, Bemis G. Sample genetic policy language for research conducted with native communities. J Cancer Educ. 2005 Spr; 20(1 Suppl S):52-7.
    View PubMed
  57. Petereit DG, Rogers D, Burhansstipanov L, Kaur J, Govern F, Howard SP, Osburn CH, Coleman N, Fowler JE, Chappell R, Mehta MP. Walking Forward: The South Dakota Native American project. J Cancer Educ. 2005 Spr; 20(1 Suppl S):65-70.
    View PubMed
  58. Galanis E, Burch PA, Richardson RL, Lewis B, Pitot HC, Frytak S, Spier C, Akporiaye ET, Peethambaram PP, Kaur JS, Okuno SH, Unni KK, Rubin J. Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma. Cancer. 2004 Dec 1; 101(11):2557-66.
    View PubMed
  59. Burch PA, Croghan GA, Gastineau DA, Jones LA, Kaur JS, Kylstra JW, Richardson RL, Valone FH, Vuk-Pavlovic S. Immunotherapy (APC8015, Provenge((R))) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: A phase 2 trial. Prostate. 2004 Aug 1; 60(3):197-204.
    View PubMed
  60. Kaur JS, Roubidoux MA, Sloan J, Novotny P. Can the Gail model be useful in American Indian and Alaska Native populations? Cancer. 2004 Mar 1; 100(5):906-12.
    View PubMed
  61. Roubidoux M, Kaur J, Griffiths K, Novotny P, Stillwater B, Sloan J A pilot study of the relationship of mammographic parenchymal patterns with breast cancer risk factors and smoking in Alaska Native women Cancer Epidemiology Biomarkers and Prevention. 2004.
    View PubMed
  62. Petersen WO, Trapp MA, Sellers TA, Nicometo AM, Kaur JS. Evaluation of a training program to prepare community health representatives to promote breast and cervix cancer screening among native American women. J Cancer Educ. 2004 Win; 19(4):237-43.
    View PubMed
  63. Gill P, Kaur JS, Rummans T, Novotny PJ, Sloan JA. The hospice patient's primary caregiver. What is their quality of life? J Psychosom Res. 2003 Nov; 55(5):445-51.
    View PubMed
  64. Kaur JS. Cancer Health Disparities. Cancer Plan Minnesota. 2003 Oct 2.
  65. Roubidoux MA, Kaur JS, Griffith KA, Stillwater B, Novotny P, Sloan J. Relationship of mammographic parenchymal patterns to breast cancer risk factors and smoking in Alaska native women. Cancer Epidemiol Biomarkers Prev. 2003 Oct; 12(10):1081-6.
    View PubMed
  66. Petersen WO, Trapp MA, Fanale MA, Kaur JS. Evaluating the WEB training program for cancer screening in Native American women. Holist Nurs Pract. 2003 Sep-Oct; 17(5):262-75.
    View PubMed
  67. Roubidoux MA, Kaur JS, Griffith KA, Sloan J, Wilson C, Novotny P, Lobell M. Correlates of mammogram density in southwestern Native-American women. Cancer Epidemiol Biomarkers Prev. 2003 Jun; 12(6):552-8.
    View PubMed
  68. Petersen W Trapp MA de Groen PC, Kaur JS. A Proposal for Documenting and Guiding Health Care Providers’ Post Training Behaviors When Close and Timely Monitoring of Performance and Feedback Are Difficult to Provide. Eastern Educational Research Association's annual meeting. Hilton Head, SC. February 26-March 2, 2003.
  69. Qu GZ, Kaur JS, Seward JB. Metastatic melanoma presenting as cardiac mass and hemobilia. Am J Med Sci. 2003 Mar; 325(3):157-9.
    View PubMed
  70. Burhansstipanov L, Kaur JS, Krebs LU. Clinical trials education for Native Americans. National Indian Health Board Health Reporter Newsletter. 2003; 10(1):7, 15.
  71. Burhansstipanov L, Krebs LU, Bradley A, Gamito E, Osborn K, Dignan MB, Kaur JS. Lessons learned while developing “Clinical Trials Education for Native Americans” curriculum. Cancer Control. 2003; 10(5):29-36.
    View PubMed
  72. Strickland R, Pierce K, Stephenson L, Miller-Korth N, Knutsen K, Waukau J, Remington P, Kaur J. Building cancer surveillance capacity: Wisconsin tribal and urban Indian clinics. The IHS Primary Care Provider. 2003; 28(12):261-6.
  73. Markovic SN, Suman VJ, Vukov AM, Fitch TR, Hillman DW, Adjei AA, Alberts SR, Kaur JS, Braich TA, Creagan ET. Phase II trial of KW2189 in patients with advanced malignant melanoma. Am J Clin Oncol. 2002 Jun; 25(3):308-12.
    View PubMed
  74. Sellers TA, Trapp MA, Vierkant RA, Petersen W, Kottke TE, Jensen A, Kaur JS. Evaluation of a program to train nurses to screen for breast and cervical cancer among Native American women. J Cancer Educ. 2002 Spring; 17(1):24-7.
    View PubMed
  75. Petersen WO, Trapp MA, Vierkant RA, Sellers TA, Kottke TE, de Groen PC, Nicometo AM, Kaur JS. Outcomes of training nurses to conduct breast and cervical cancer screening of Native American women. Holist Nurs Pract. 2002 Jan; 16(2):58-79.
    View PubMed
  76. Kaur JS, Hamptom J, Burhansstipanov L, Krebs LU. Clinical Trials Education for Native American Providers. Association of American Indian Physicians 30th Anniversary Proceedings. 2001 Aug 12.
  77. Riegert-Johnson DL, Kaur JS, Pfeifer EA. Calciphylaxis associated with cholangiocarcinoma treated with low-molecular-weight heparin and vitamin K. Mayo Clin Proc. 2001 Jul; 76(7):749-52.
    View PubMed
  78. Kaur JS. Breast cancer prevention and detection techniques. Postgrad Obstet Gynecol. 2001; 21(1):1-5.
  79. Burch PA, Richardson RL, Cha SS, Sargent DJ, Pitot HC 4th, Kaur JS, Camoriano JK. Phase II study of paclitaxel and cisplatin for advanced urothelial cancer. J Urol. 2000 Nov; 164(5):1538-42.
    View PubMed
  80. Giroux J, Welty TK, Oliver FK, Kaur JS, Leonardson G, Cobb N. Low national breast and cervical cancer-screening rates in American Indian and Alaska Native women with diabetes. J Am Board Fam Pract. 2000 Jul-Aug; 13(4):239-45.
    View PubMed
  81. Burch PA, Breen JK, Buckner JC, Gastineau DA, Kaur JA, Laus RL, Padley DJ, Peshwa MV, Pitot HC, Richardson RL, Smits BJ, Sopapan P, Strang G, Valone FH, Vuk-Pavlovic S. Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer. Clin Cancer Res. 2000 Jun; 6(6):2175-82.
    View PubMed
  82. Kaur JS. Migration patterns and breast carcinoma. Cancer. 2000 Mar 1; 88(5 Suppl):1203-6.
    View PubMed
  83. Storen EC, Hay JE, Kaur J, Zahasky K, Hartmann L. Tamoxifen-induced submassive hepatic necrosis. Cancer J. 2000 Mar-Apr; 6(2):58-60.
    View PubMed
  84. Kaur JS. Palliative care and hospice programs. Mayo Clin Proc. 2000 Feb; 75(2):181-3; quiz 183-4.
    View PubMed
  85. Trapp MA, Kottke TE, Vierkant RA, Kaur JS, Sellers TA. The ability of trained nurses to detect lumps in a test set of silicone breast models. Cancer. 1999 Nov 1; 86(9):1750-6.
    View PubMed
  86. Kaur JS. Native women and cancer. Health Care Women Int. 1999 Sep-Oct; 20(5):445-53.
    View PubMed
  87. Bretscher M, Rummans T, Sloan J, Kaur J, Bartlett A, Borkenhagen L, Loprinzi C. Quality of life in hospice patients. A pilot study. Psychosomatics. 1999 Jul-Aug; 40(4):309-13.
    View PubMed
  88. Roubidoux MA, Kaur JS, Giroux J. Mammographic findings and family history risk for breast cancer in American Indian women. Cancer. 1998 Oct 15; 83(8 Suppl S):1830-2.
  89. Loprinzi CL, Abu-Ghazaleh S, Sloan JA, vanHaelst-Pisani C, Hammer AM, Rowland KM Jr, Law M, Windschitl HE, Kaur JS, Ellison N. Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer. J Clin Oncol. 1997 Mar; 15(3):969-73.
    View PubMed
  90. Kaur JS. The potential impact of cancer survivors on Native American cancer prevention and treatment. Cancer. 1996 Oct 1; 78(7 Suppl):1578-81.
    View PubMed
  91. Kaur JS. Helping the Native American cancer patient, their family and community. Alaska Med. 1993 Oct-Dec; 35(4):297-300.
    View PubMed
  92. Davis T, Miser AW, Loprinzi CL, Kaur JS, Burnham NL, Dose AM, Ames MM. Comparative morphine pharmacokinetics following sublingual, intramuscular, and oral administration in patients with cancer. Hosp J. 1993; 9(1):85-90.
    View PubMed
  93. Connerton IF, Kaur JS, Rogers S, Park RW. Isolation and characterization of a cryptic plasmid from mesophilic aeromonads: potential as a cloning vector. Lett Appl Microbiol. 1991 Jan; 12(1):16-9.
    View PubMed
  94. Rifkin RM, Thomas MR, Mughal TI, Kaur JS, Krebs LU, Robinson WA. Malignant melanoma--profile of an epidemic. West J Med. 1988 Jul; 149(1):43-6.
    View PubMed
  95. Thomas PJ, Kaur JS, Aitcheson CT, Robinson WA, Tan EM. Antinuclear, antinucleolar, and anticytoplasmic antibodies in patients with malignant melanoma. Cancer Res. 1983 Mar; 43(3):1372-80.
    View PubMed
  96. Kaur JS, Goldberg JP, Schrier RW. Acute renal failure following arteriography in a patient with polyarteritis nodosa. JAMA. 1982 Feb 12; 247(6):833-4.
    View PubMed